A multiplex methylation-specific PCR assay for the detection of early-stage ovarian cancer using cell-free serum DNA

Gynecologic Oncology

Volumn 130, Issue 1, 2013, Pages 132-139

  Zhang, Qing ^a   Hu, Guohong ^b   Yang, Qifeng ^a   Dong, Ruifen ^a   Xie, Xing ^c   Ma, Ding ^d   Shen, Keng ^e   Kong, Beihua ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Cell free serum DNA; Early detection; Epithelial ovarian cancer; Multiplex methylation specific PCR assay

Indexed keywords

APC PROTEIN; CA 125 ANTIGEN; DNA; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; SECRETED FRIZZLED RELATED PROTEIN 5; TRANSCRIPTION FACTOR RUNX3; UVOMORULIN;

ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER SCREENING; CONTROLLED STUDY; DNA METHYLATION; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

CA-125 ANTIGEN; CELL LINE, TUMOR; DNA METHYLATION; DNA, NEOPLASM; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MEMBRANE PROTEINS; NEOPLASM GRADING; NEOPLASM STAGING; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84879095890     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.04.048     Document Type: Article

References (49)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. R.P. Woolas, F.J. Xu, I.J. Jacobs, Y.H. Yu, L. Daly, and A. Berchuck Elevation of multiple serum markers in patients with stage I ovarian cancer J Natl Cancer Inst 85 1993 1748 1751
3. I.J. Jacobs, and U. Menon Progress and challenges in screening for early detection of ovarian cancer Mol Cell Proteomics 3 2004 355 366
4. U. Menon, and I.J. Jacobs Recent developments in ovarian cancer screening Curr Opin Obstet Gynecol 12 2000 39 42
5. A. Munkarah, M. Chatterjee, and M.A. Tainsky Update on ovarian cancer screening Curr Opin Obstet Gynecol 19 2007 22 26
6. G. Egger, G. Liang, A. Aparicio, and P.A. Jones Epigenetics in human disease and prospects for epigenetic therapy Nature 429 2004 457 463
7. J.F. Costello, and C. Plass Methylation matters J Med Genet 38 2001 285 303
8. J.G. Herman, and S.B. Baylin Gene silencing in cancer in association with promoter hypermethylation N Engl J Med 349 2003 2042 2054
9. J.P. Issa DNA methylation as a therapeutic target in cancer Clin Cancer Res 13 2007 1634 1637
10. J. Zhu, and X. Yao Use of DNA methylation for cancer detection and molecular classification J Biochem Mol Biol 40 2007 135 141
11. S.A. Leon, B. Shapiro, D.M. Sklaroff, and M.J. Yaros Free DNA in the serum of cancer patients and the effect of therapy Cancer Res 37 1977 646 650
12. E. Perlin, and R.B. Moquin Serum DNA levels in patients with malignant disease Am J Clin Pathol 58 1972 601 602
13. R.E. Board, L. Knight, A. Greystoke, F.H. Blackhall, A. Hughes, and C. Dive DNA methylation in circulating tumour DNA as a biomarker for cancer Biomark Insights 2 2008 307 319
14. V.V. Vlassov, P.P. Laktionov, and E.Y. Rykova Circulating nucleic acids as a potential source for cancer biomarkers Curr Mol Med 10 2010 142 165
15. M.V. Brock, C.M. Hooker, E. Ota-Machida, Y. Han, M. Guo, and S. Ames DNA methylation markers and early recurrence in stage I lung cancer N Engl J Med 358 2008 1118 1128
16. C. Lofton-Day, F. Model, T. Devos, R. Tetzner, J. Distler, and M. Schuster DNA methylation biomarkers for blood-based colorectal cancer screening Clin Chem 54 2008 414 423
17. S.S. Buys, E. Partridge, A. Black, C.C. Johnson, L. Lamerato, and C. Isaacs Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial JAMA 305 2011 2295 2303
18. U. Menon, A. Gentry-Maharaj, R. Hallett, A. Ryan, M. Burnell, and A. Sharma Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) Lancet Oncol 10 2009 327 340
19. The guide to clinical preventive services 2010-2011: recommendations of the U.S. preventive services task force 2010 The Agency for Healthcare Research and Quality (AHRQ) Rockville MD
20. A.B. Philipp, P. Stieber, D. Nagel, J. Neumann, F. Spelsberg, and A. Jung Prognostic role of methylated free circulating DNA in colorectal cancer Int J Cancer 131 2012 2308 2319
21. S. Yagyu, T. Gotoh, T. Iehara, M. Miyachi, Y. Katsumi, and S. Tsubai-Shimizu Circulating methylated-DCR2 gene in serum as an indicator of prognosis and therapeutic efficacy in patients with MYCN nonamplified neuroblastoma Clin Cancer Res 14 2008 7011 7019
22. T.E. Liggett, A. Melnikov, Q. Yi, C. Replogle, W. Hu, and J. Rotmensch Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors Gynecol Oncol 120 2011 113 120
23. I. Ibanez de Caceres, C. Battagli, M. Esteller, J.G. Herman, E. Dulaimi, and M.I. Edelson Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients Cancer Res 64 2004 6476 6481
24. J.Z. Song, C. Stirzaker, J. Harrison, J.R. Melki, and S.J. Clark Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells Oncogene 21 2002 1048 1061
25. C.A. Barton, N.F. Hacker, S.J. Clark, and P.M. O'Brien DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment Gynecol Oncol 109 2008 129 139
26. G.C. Sellar, K.P. Watt, G.J. Rabiasz, E.A. Stronach, L. Li, and E.P. Miller OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer Nat Genet 34 2003 337 343
27. J.M. Teodoridis, J. Hall, S. Marsh, H.D. Kannall, C. Smyth, and J. Curto CpG island methylation of DNA damage response genes in advanced ovarian cancer Cancer Res 65 2005 8961 8967
28. A. Czekierdowski, S. Czekierdowska, M. Szymanski, M. Wielgos, P. Kaminski, and J. Kotarski Opioid-binding protein/cell adhesion molecule-like (OPCML) gene and promoter methylation status in women with ovarian cancer Neuro Endocrinol Lett 27 2006 609 613
29. E. Gormally, E. Caboux, P. Vineis, and P. Hainaut Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance Mutat Res 635 2007 105 117
30. B. Shapiro, M. Chakrabarty, E.M. Cohn, and S.A. Leon Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease Cancer 51 1983 2116 2120
31. S. Jahr, H. Hentze, S. Englisch, D. Hardt, F.O. Fackelmayer, and R.D. Hesch DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells Cancer Res 61 2001 1659 1665
32. M.F. Fraga, and M. Esteller DNA methylation: a profile of methods and applications Biotechniques 33 2002 [632, 4, 6-49]
33. N. Yamamoto, T. Nakayama, M. Kajita, T. Miyake, T. Iwamoto, and S.J. Kim Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARbeta2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay Breast Cancer Res Treat 132 2012 165 173
34. K. Hibi, M. Taguchi, H. Nakayama, T. Takase, Y. Kasai, and K. Ito Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma Clin Cancer Res 7 2001 3135 3138
35. H. Usadel, J. Brabender, K.D. Danenberg, C. Jeronimo, S. Harden, and J. Engles Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer Cancer Res 62 2002 371 375
36. A. Rathi, A.K. Virmani, J.O. Schorge, K.J. Elias, R. Maruyama, and J.D. Minna Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk women Clin Cancer Res 8 2002 3324 3331
37. P.B. Makarla, M.H. Saboorian, R. Ashfaq, K.O. Toyooka, S. Toyooka, and J.D. Minna Promoter hypermethylation profile of ovarian epithelial neoplasms Clin Cancer Res 11 2005 5365 5369
38. Q. Wu, R.A. Lothe, T. Ahlquist, I. Silins, C.G. Trope, and F. Micci DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets Mol Cancer 6 2007 45
39. K.F. Tam, V.W. Liu, S.S. Liu, P.C. Tsang, A.N. Cheung, and A.M. Yip Methylation profile in benign, borderline and malignant ovarian tumors J Cancer Res Clin Oncol 133 2007 331 341
40. A. Agathanggelou, S. Honorio, D.P. Macartney, A. Martinez, A. Dallol, and J. Rader Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours Oncogene 20 2001 1509 1518
41. A.E. Bondurant, Z. Huang, R.S. Whitaker, L.R. Simel, A. Berchuck, and S.K. Murphy Quantitative detection of RASSF1A DNA promoter methylation in tumors and serum of patients with serous epithelial ovarian cancer Gynecol Oncol 123 2011 581 587
42. M. Cul'bova, Z. Lasabova, A. Stanclova, P. Tilandyova, P. Zubor, and R. Fiolka Methylation of selected tumor-supressor genes in benign and malignant ovarian tumors Ceska Gynekol 76 2011 274 279
43. J.H. Yoon, R. Dammann, and G.P. Pfeifer Hypermethylation of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas Int J Cancer 94 2001 212 217
44. S. Zhang, L. Wei, A. Zhang, L. Zhang, and H. Yu RUNX3 gene methylation in epithelial ovarian cancer tissues and ovarian cancer cell lines OMICS 13 2009 307 311
45. Y. Yuecheng, L. Hongmei, and X. Xiaoyan Clinical evaluation of E-cadherin expression and its regulation mechanism in epithelial ovarian cancer Clin Exp Metastasis 23 2006 65 74
46. K. Hibi, T. Goto, Y.H. Kitamura, K. Yokomizo, K. Sakuraba, and A. Shirahata Methylation of TFPI2 gene is frequently detected in advanced well-differentiated colorectal cancer Anticancer Res 30 2010 1205 1207
47. N. Sato, A.R. Parker, N. Fukushima, Y. Miyagi, C.A. Iacobuzio-Donahue, and J.R. Eshleman Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma Oncogene 24 2005 850 858
48. C.M. Ho, H.C. Lai, S.H. Huang, T.Y. Chien, M.C. Lin, and S.F. Chang Promoter methylation of sFRP5 in patients with ovarian clear cell adenocarcinoma Eur J Clin Invest 40 2010 310 318
49. H.Y. Su, H.C. Lai, Y.W. Lin, C.Y. Liu, C.K. Chen, and Y.C. Chou Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway Int J Cancer 127 2010 555 567